• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Alkermes plc (ALKS)

    -NasdaqGS
    72.80 Up 1.33(1.86%) 4:00PM EST
    |After Hours : 71.50 Down 1.30 (1.79%) 4:18PM EST
    Add to Portfolio
    Prev Close:71.47
    Open:71.75
    Bid:69.90 x 100
    Ask:72.79 x 100
    1y Target Est:71.90
    Beta:1.31
    Next Earnings Date:N/A
    Day's Range:70.07 - 72.84
    52wk Range:38.49 - 74.96
    Volume:1,222,445
    Avg Vol (3m):1,335,200
    Market Cap:10.78B
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 1.86%10.78B
    ABTDown 0.28%71.06B
    LLYDown 1.05%74.64B
    GSKDown 0.46%114.77B

    Key Statistics

    Forward P/E (1 yr):560.00
    P/S (ttm):17.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.32
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-31.46

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback